We Are IU
Ozempic and similar GLP-1 drugs—with their quick weight-loss effects—have become ubiquitous topics in health care and popular culture. While this new frontier of pharmaceuticals became wildly popular in just a few years, the science took decades to develop. Much of the research and innovation have ties to Indiana University, and a key player is IU Distinguished Professor Richard DiMarchi. In this episode, DiMarchi discusses the trend of GLP-1s and his contributions to the research that made them possible.
12 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der We Are IU-Community!